Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Rare Cannabinoid Company's Labor Day Sale Starts Now: 40% Off 3000mg CBD To Pair With THCV, Delta-8-THC, CBN, CBG, CBC and CBDA

Rare Cannabinoid Company launched its Labor Day Sale: 1000mg full spectrum Rare Hawaiian CBD and extra high strength 3000mg CBD drop to $59 (regular prices are $99 and $79 respectively.) Customers can stock up on CBD to combine with the brand's apothecary of cannabinoids: THCV, Delta-8-THC, CBN, CBG, CBC and CBDA.


News provided by

Rare Cannabinoid Company

Sep 02, 2021, 22:55 ET

Share this article

Share toX

Share this article

Share toX

Labor Day Sale! Extra strength 3000mg CBD and 1000mg full spectrum Rare Hawaiian CBD are on sale for just $59 each! (Regular prices: $99 and $79)
Labor Day Sale! Extra strength 3000mg CBD and 1000mg full spectrum Rare Hawaiian CBD are on sale for just $59 each! (Regular prices: $99 and $79)

HONOLULU, Sept. 2, 2021 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company launched its Labor Day Sale, offering up to 40% off CBD to combine with its single extracts of THCV, Delta-8-THC, CBN, CBG, CBC and CBDA.

For a limited time, customers can purchase 1000mg full spectrum Rare Hawaiian CBD and extra high strength 3000mg CBD oil tinctures for just $59 (regular prices are $79 and $99 respectively.)

“Our sale price of $59 is really a steal for such a strong CBD product,” said Dalgamouni.

Post this

"We are offering this deep discount so that our customers can get the full benefits of our apothecary line of cannabinoids," said company founder and CEO, Jared Dalgamouni.

"Each rare cannabinoid is believed to offer specific health and wellness benefits, but they work best when combined with each other or a full spectrum CBD for the entourage effect," he said.

"For example, THCV can be taken with CBD for a morning boost and appetite control while an evening combination of CBN and CBD may help with relaxation and sleep," he said.

Rare Cannabinoid Company's 1000mg CBD oil tincture contains full spectrum CBD extracted from premium Hawaiian hemp. The plants are grown in the "up-country" Kula region on the island of Maui. This verdant agricultural area is on the western-facing slopes of the dormant volcano Haleakala. The land receives year-round tropical sunshine and rain and has a cooler climate than Hawaii's coastal beach areas. The Hawaiian CBD is carried in certified organic MCT coconut oil and is gently flavored with food grade organic essential oils of Italian lemon and wild orange.

Meanwhile, the 3000mg CBD oil is so strong that it's the only Rare Cannabinoid Company product that comes with a glass dropper instead of a spray cap for precision dosing. A serving size is considered 0.25 ml (25mg CBD), which means that there are a whopping 120 servings per 30ml bottle.

"Our sale price of $59 is really a steal for such a strong CBD product," said Dalgamouni.
"We hope that it will allow our customers to experience the concept of mixing and matching cannabinoids to really figure out what works best for them," he said.

Customers can get a further 15% off all products ordered with an auto-ship subscription. This brings the price of the CBD oils down to $50.15 each. Subscriptions can be cancelled online without any penalties or fees at any time. See how rare cannabinoid subscriptions work here.

Rare Cannabinoid Company was the first to conceptualize an apothecary of cannabinoids. The idea is that depending on the time of day or one's mental and physical needs, they can customize their own personal blend using the brand's 500mg single extracts of THCV, Delta-8-THC, CBN, CBG, CBC and CBDA. Rare Cannabinoid Company was the first brand to produce a purified THCV oil tincture and will soon be the first to launch a CBDV oil tincture as well as terpene-only tinctures for relaxation and relief.

Here is a brief definition of each cannabinoid with links to news articles and research:
THCV (tetrahydrocannabivarin): Believed to boost energy and suppress appetite.
Leafly: Everything You Need To Know About THCV
LA Weekly: The Best THCV for Energy and Weight Loss
High Times: THCV, CBN and CBG: Learn which Rare Cannabinoid is Best for Weight Loss, Sleep or Pain
Learn more and buy THCV here.

Delta-8-THC (Delta-8-tetrahydrocannabinol): May offer a feeling of euphoria and ease discomfort and nausea.
High Times: 8 Reasons To Try Delta-8-THC Before It's Too Late
Learn more and buy Delta-8-THC here.

CBN (cannabinol): Supports rest, relaxation and sleep.
L.A. Weekly: CBN for Sleep: Your Guide to the Most Sedative Cannabinoid
Learn more and buy CBN oil here.

CBG (cannabigerol): May ease discomfort and supports brain and body health.
Leafly: Is CBG better than CBD and THC for pain, inflammation, and aging?
Learn more and buy CBG oil here.

CBC (cannabichromene): Supports mental health and may improve mood
Leafly: Nature's antidepressant? Rare cannabinoid CBC boosts the brain's 'bliss' molecule
Learn more and buy CBC oil here.

CBDA (cannabidiolic acid): May reduce nausea and reduce inflammation from everyday activities.
Learn more and buy CBDA here.

CBDV (cannabidivarin): CBDV studies are looking into its potential uses for inflammation, autism spectrum disorder, muscular dystrophy and seizures.
Learn more and buy CBDV here(coming mid-September).

Relax terpene-only tincture: Blend of pure terpenes β-Myrcene, β-Pinene, δ-3-Carene, δ-Limonene, Linalool promotes calm, relaxation, stress resilience and restful sleep.
Learn more and buy Relax terpene-only tincture here (coming mid-September).

Relief terpene-only tincture: Blend of pure terpenes α-Pinene, δ-Limonene, Linalool and β-Caryophyllene may reduce inflammation related to activity, speed up the recovery process and support healthy joints.
Learn more and buy Relief terpene-only tincture here (coming mid-September).

All Rare Cannabinoid Company products are produced in a cGMP facility. For full peace of mind, third-party lab test results are available online and via QR code on the product packaging.

Rare Cannabinoid Company was started by the owners of Hawaiian Choice, Hawaii's most-popular CBD brand. Hawaiian Choice offers CBD tinctures, a cooling CBD topical balm, and vegan CBD gummies, all made with broad spectrum Hawaiian CBD and infused with real Hawaiian fruits, essential oils or honey. Both brands are sold in more than 200 locations across the United States and online. Hawaiian Choice is also sold across Japan and the Mariana Islands.
Brick and mortar stores interested in stocking products from Rare Cannabinoid Company and Hawaiian Choice CBD can learn more and apply for a wholesale account here.

Media Contact

Jennifer Carlile, Rare Cannabinoid Company, (808)762-1313, [email protected]

Twitter, Facebook

SOURCE Rare Cannabinoid Company

Modal title

Rare Cannabinoid Company offers an apothecary of wellness tinctures: THCV, Delta-8-THC, CBN, CBG, CBC, CBDA, CBD and will soon sell CBDV and terpene-only tinctures.
Rare Cannabinoid Company offers an apothecary of wellness tinctures: THCV, Delta-8-THC, CBN, CBG, CBC, CBDA, CBD and will soon sell CBDV and terpene-only tinctures.
Rare Cannabinoid Company offers an apothecary of wellness tinctures: THCV, Delta-8-THC, CBN, CBG, CBC, CBDA, CBD and will soon sell CBDV and terpene-only tinctures.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.